Gene · 2549
Papers2,374
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,374
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma. | Cancer Res | 2020 | 33046443 | PubTator, text mining | PubMed |
| A Computational Framework for Prediction and Analysis of Cancer Signaling Dynamics from RNA Sequencing Data-Application to the ErbB Receptor Signaling Pathway. | Cancers (Basel) | 2020 | 33036375 | PubTator, text mining | PubMed |
| Multifocal Medulloblastoma in an Adult Patient: Description of a Rare Presentation and Review of the Literature. | Case Rep Pathol | 2020 | 33005468 | PubTator, text mining | PubMed |
| Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment. | Cancers (Basel) | 2020 | 33003469 | PubTator, text mining | PubMed |
| Structural modelling of the lumenal domain of human GPAA1, the metallo-peptide synthetase subunit of the transamidase complex, reveals zinc-binding mode and two flaps surrounding the active site. | Biol Direct | 2020 | 32993792 | PubTator, text mining | PubMed |
| The role of microenvironment in tumor angiogenesis. | J Exp Clin Cancer Res | 2020 | 32993787 | PubTator, text mining | PubMed |
| DNA Methylome Distinguishes Head and Neck Cancer from Potentially Malignant Oral Lesions and Healthy Oral Mucosa. | Int J Mol Sci | 2020 | 32961999 | PubTator, text mining | PubMed |
| Expression correlation attenuates within and between key signaling pathways in chronic kidney disease. | BMC Med Genomics | 2020 | 32957963 | PubTator, text mining | PubMed |
| The significance of microRNA deregulation in colorectal cancer development and the clinical uses as a diagnostic and prognostic biomarker and therapeutic agent. | Noncoding RNA Res | 2020 | 32954092 | PubTator, text mining | PubMed |
| Identification of novel fusion transcripts in meningioma. | J Neurooncol | 2020 | 32949309 | PubTator, text mining | PubMed |
| The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators that Inhibit their Activity. | Int J Mol Sci | 2020 | 32948029 | PubTator, text mining | PubMed |
| PLCγ1‑dependent invasion and migration of cells expressing NSCLC‑associated EGFR mutants. | Int J Oncol | 2020 | 32945365 | PubTator, text mining | PubMed |
| Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer. | Nat Commun | 2020 | 32929081 | PubTator, text mining | PubMed |
| Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer. | Sci Rep | 2020 | 32913236 | PubTator, text mining | PubMed |
| Neurotrophin Signaling in Medulloblastoma. | Cancers (Basel) | 2020 | 32906676 | PubTator, text mining | PubMed |
| Epigenome-wide association study for transgenerational disease sperm epimutation biomarkers following ancestral exposure to jet fuel hydrocarbons. | Reprod Toxicol | 2020 | 32905848 | PubTator, text mining | PubMed |
| Pre- and Post-Zygotic TP53 De Novo Mutations in SHH-Medulloblastoma. | Cancers (Basel) | 2020 | 32899294 | PubTator, text mining | PubMed |
| The cell-surface anchored serine protease TMPRSS13 promotes breast cancer progression and resistance to chemotherapy. | Oncogene | 2020 | 32868877 | PubTator, text mining | PubMed |
| Interaction of the Hippo Pathway and Phosphatases in Tumorigenesis. | Cancers (Basel) | 2020 | 32867200 | PubTator, text mining | PubMed |
| Lowering Sample Requirements to Study Tyrosine Kinase Signaling Using Phosphoproteomics with the TMT Calibrator Approach. | Proteomics | 2020 | 32865326 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2549/papers?page=40